2nd Quarter - Report

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

Firm
Client
Income
—
Expenses
$1,160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

HR 942 American Research and Competitiveness Act - reauthorization of research and development tax credit

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 942 (112th)

Copyright/Patent/Trademark CPT

S 23, HR 1249 America Invents Act - provisions related to supplemental examination, first inventor to file, best mode, and false marking

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
STEPHEN SCANGO New Legislative Assistant, Rep. Michael Castle
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1249 (112th)

Health Issues HCR

PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions HR 452 Medicare Decisions Accountability Act - repeal of Independent Payment Advisory Board (IPAB) S 668 Health Care Bureaucrats Elimination Act - repeal of Independent Payment Advisory Board (IPAB) HR 1930 Access to Appropriate Immunizations for Veterans Act of 2011- extending VA performance measures to include all federally recommended vaccines HR 2405 Pandemic and All Hazards Preparedness Act - Re-authorization; influenza vaccine innovative technologies S 1002 Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) drug safety HR 1483 The Drug Safety Enhancement Act of 2011- drug safety standards HR 2182 Generating Antibiotic Incentives Now Act of 2011Provisions related to antibiotics and incentives ADDENDUM/General Lobbying Issue Area - Federal Food, Drug, and Cosmetic Act (currently unassigned) - section related to FDA and regulation of nicotine replacement therapies

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1930 (112th), H.R. 2182 (112th), H.R. 452 (112th), H.R. 2405 (112th), H.R. 1483 (112th)

Medicare/Medicaid MMM

PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - Medicare and Medicaid payment, Medicare Part D coverage gap, 340B drug pricing, meaningful use Part D benefit; quality measures; COPD maintenance treatment

LobbyistCovered position, as disclosed
LYNDA BRYANT-COMSTOCK New —
JOHN DEL GIORNO —
GARY HEIMBERG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Budget/Appropriations BUD

HR 2112 Fiscal Year 2012 Agriculture Appropriations - provisions pertaining to Ryan White CARE Act, FDA funding HR 1473 The Department of Defense and Full Year Continuing Appropriations Act - provisions pertaining to Ryan White CARE Act, FDA funding Fiscal Year 2012 Labor-HHS-Education Appropriations - FY 2012 HHS Budget Request; proposal relating to Vaccine Section 317 program, Ryan White CARE Act PL 111-148, PL 111-152 Patient Protection and Affordable Care Act - FY 2011 Prevention and Public Health Fund; allocations for Vaccine Section 317 program and smoking cessation programs HR 2190, S 1206Medicare Drug Savings ActMedicare drug rebates

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2112 (112th), H.R. 1473 (112th), H.R. 2190 (112th)

Pharmacy PHA

ADDENDUM/General Lobbying Issue Area - Prescription Drug User Fee Act PDUFA-V (currently unassigned) - issues related to reauthorization of the Prescription Drug User Fee Act

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Torts TOR

HR 5, S 218 Help Efficient, Accessible, Low-cost, Timely Healthcare Act - provisions relating to various medical malpractice and civil justice reforms HR 605, S 312 Patients Freedom to Choose Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts

LobbyistCovered position, as disclosed
JOHN DEL GIORNO —
GARY HEIMBERG —
WILLIAM J SCHUYLER —
SARAH J WALSH —
KIMBERLY A WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 5 (112th), H.R. 605 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.